English  |  正體中文  |  简体中文  |  2831143  
???header.visitor??? :  33147643    ???header.onlineuser??? :  996
???header.sponsordeclaration???
 		 
???search.scope??? ???search.advance???
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???
???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
Repositories
Author
Title
Date
???ui.leftmenu.statisticschart???
???ui.leftmenu.realtimefacts???
???ui.leftmenu.trend???

???index.news???
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

???ui.leftmenu.copyrighttitle???
???ui.leftmenu.copyrightpublisher???
???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
???tair.name??? >  ???browser.page.title.author???

"diaz padilla i"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-6 of 6  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-05-25T06:51:46Z Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial Franke F; Bardia A; Harbeck N; Hurvitz S.A; Chow L; Sohn J; Lee K.S; Campos-Gomez S; Villanueva Vazquez R; Jung K.H; Babu K.G; Wheatley-Price P; De Laurentiis M; Im Y.-H; Kuemmel S; El-Saghir N; Liu M.-C; Carlson G; Hughes G; Diaz-Padilla I; Germa C; Hirawat S; YEN-SHEN LU; Colleoni M; Im S.-A; Tripathy D; Tripathy D;Im S.-A;Colleoni M;Franke F;Bardia A;Harbeck N;Hurvitz S.A;Chow L;Sohn J;Lee K.S;Campos-Gomez S;Villanueva Vazquez R;Jung K.H;Babu K.G;Wheatley-Price P;De Laurentiis M;Im Y.-H;Kuemmel S;El-Saghir N;Liu M.-C;Carlson G;Hughes G;Diaz-Padilla I;Germa C;Hirawat S;Yen-Shen Lu
臺大學術典藏 2020-05-25T06:51:46Z Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial Franke F; Bardia A; Harbeck N; Hurvitz S.A; Chow L; Sohn J; Lee K.S; Campos-Gomez S; Villanueva Vazquez R; Jung K.H; Babu K.G; Wheatley-Price P; De Laurentiis M; Im Y.-H; Kuemmel S; El-Saghir N; Liu M.-C; Carlson G; Hughes G; Diaz-Padilla I; Germa C; Hirawat S; YEN-SHEN LU; Colleoni M; Im S.-A; Tripathy D; Tripathy D;Im S.-A;Colleoni M;Franke F;Bardia A;Harbeck N;Hurvitz S.A;Chow L;Sohn J;Lee K.S;Campos-Gomez S;Villanueva Vazquez R;Jung K.H;Babu K.G;Wheatley-Price P;De Laurentiis M;Im Y.-H;Kuemmel S;El-Saghir N;Liu M.-C;Carlson G;Hughes G;Diaz-Padilla I;Germa C;Hirawat S;Yen-Shen Lu
臺大學術典藏 2020-05-25T06:51:44Z Ribociclib (RIB) + non-steroidal aromatase inhibitor (NSAI) + goserelin in premenopausal Asian women with hormone-receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): Results from the randomized phase III MONALEESA-7 study Im S.-A;Sohn J;Tripathy D;Chow L;Lee K.S;Jung K.H;Babu G;Im Y.-H;El Saghir N;Liu M.-C;Diaz-Padilla I;Alam J;Kong O;Miller M;Yen-Shen Lu; Im S.-A; Sohn J; Tripathy D; Chow L; Lee K.S; Jung K.H; Babu G; Im Y.-H; El Saghir N; Liu M.-C; Diaz-Padilla I; Alam J; Kong O; Miller M; YEN-SHEN LU
臺大學術典藏 2020-05-25T06:51:44Z Ribociclib (RIB) + non-steroidal aromatase inhibitor (NSAI) + goserelin in premenopausal Asian women with hormone-receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): Results from the randomized phase III MONALEESA-7 study Im S.-A;Sohn J;Tripathy D;Chow L;Lee K.S;Jung K.H;Babu G;Im Y.-H;El Saghir N;Liu M.-C;Diaz-Padilla I;Alam J;Kong O;Miller M;Yen-Shen Lu; Im S.-A; Sohn J; Tripathy D; Chow L; Lee K.S; Jung K.H; Babu G; Im Y.-H; El Saghir N; Liu M.-C; Diaz-Padilla I; Alam J; Kong O; Miller M; YEN-SHEN LU
臺大學術典藏 2020-05-25T06:51:44Z Tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) with ribociclib (RIB) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-7 subgroup analysis Bardia A;Campos-Gomez S;Hurvitz S.A;Yen-Shen Lu;Im S.-A;Franke F;Chow L;Wheatley-Price P;Melo Cruz F;Alam J;Kong O;Diaz-Padilla I;Miller M;Tripathy D.; Bardia A; Campos-Gomez S; Hurvitz S.A; YEN-SHEN LU; Im S.-A; Franke F; Chow L; Wheatley-Price P; Melo Cruz F; Alam J; Kong O; Diaz-Padilla I; Miller M; Tripathy D.
臺大學術典藏 2020-05-25T06:51:44Z Tamoxifen (TAM) or a non-steroidal aromatase inhibitor (NSAI) with ribociclib (RIB) in premenopausal patients (pts) with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-7 subgroup analysis Bardia A;Campos-Gomez S;Hurvitz S.A;Yen-Shen Lu;Im S.-A;Franke F;Chow L;Wheatley-Price P;Melo Cruz F;Alam J;Kong O;Diaz-Padilla I;Miller M;Tripathy D.; Bardia A; Campos-Gomez S; Hurvitz S.A; YEN-SHEN LU; Im S.-A; Franke F; Chow L; Wheatley-Price P; Melo Cruz F; Alam J; Kong O; Diaz-Padilla I; Miller M; Tripathy D.

Showing items 1-6 of 6  (1 Page(s) Totally)
1 
View [10|25|50] records per page

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team